India Q2 FY27 Earnings Day: L&T, Bajaj Auto, Piramal Pharma Surge as Broad-Based Beats Emerge

The Quick Take

• India's Q2 FY27 earnings season saw results from major companies including Adani Enterprises, Adani Ports, L&T, Bajaj Auto, Maruti, TVS Motor, Hyundai, Piramal Pharma, and more.
• L&T, Bajaj Auto, Maruti, SBI Life, and Piramal Pharma shares surged following earnings beats, while LT Foods and Waaree declined.
• The batch of Q2 results across infrastructure, auto, pharma, and insurance sectors provides a broad health check on India's corporate earnings cycle.

India's Q2 FY27 earnings season reached a critical mass disclosure date with results from sector bellwethers spanning infrastructure, automotive, pharmaceuticals, insurance, and consumer goods. The pattern of surges in L&T, Bajaj Auto, Maruti, SBI Life, and Piramal Pharma shares reflects broad earnings beats across these verticals, consistent with India's sustained economic growth momentum and corporate profit margins recovering from the post-pandemic normalization phase. The strength in L&T specifically — an infrastructure conglomerate — validates government capital expenditure pass-through into private sector order books.

The contrast between surging infrastructure and auto names versus declining LT Foods and Waaree highlights selective differentiation within the broader India Q2 earnings beat: commodity-exposed or export-oriented businesses face more variable profit cycles than domestic infrastructure and consumption plays. Hyundai India's results as a newly listed entity attract particular scrutiny given its high-profile IPO valuation and investor expectations for margin expansion versus its parent company's global footprint. Vedanta's results carry commodity price sensitivity that links to global base metals market conditions.

Forward signals include the full year FY27 guidance updates from L&T on infrastructure order pipeline and Bajaj Auto on two-wheeler export demand, the RBI's rate policy direction which affects consumer auto financing rates, and India's fiscal deficit trajectory which determines the government's capital expenditure sustainability. The macro variable is India's GDP growth trajectory for FY27 — strong GDP above 7% supports all domestic consumption and infrastructure earnings in the basket, while any deceleration would pressure revenue guidance revisions.

Synthesized from 1 source.